Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : World Outlook -- Ignore unavailable to you. Want to Upgrade?

To: Les H who wrote (45829)	5/10/2025 4:21:10 AM
From: Les H	Read Replies (2) \| Respond to of 48770

Rest Up, Biopharma. Trump’s Drug Pricing Policy Is Coming on Monday May 9, 2025 Annalee Armstrong With President Donald Trump expected to deliver a drug pricing order on Monday that Big Pharma and patient groups alike have railed against, the industry’s tumultuous ride is far from over. The biopharma world has been waiting with bated breath to see what President Donald Trump will do with the Inflation Reduction Act. Next week, we may finally know, as Trump teased in the Oval Office on Monday that a major drug pricing initiative is coming next week. The IRA has been extremely maligned by the industry, particularly the “ pill penalty,” referring to the IRA’s longer period of protection from price negotiations for biologics than for small molecules. The industry contends this penalizes innovation, and Trump has actually shown support for equalizing the two drug classes. At the time, BMO heralded the order as long-overdue “good news from DC.” But now, the analyst firm is asking: “Can we catch a break?” That’s because BMO predicts that Trump’s anticipated executive order will direct Health and Human Services to use international drug prices in the negotiations that are already scheduled to happen under the IRA. [url=https://www.biospace.com/policy/rest-up-biopharma-trumps-drug-pricing-policy-is-coming-on-monday]https://www.biospace.com/policy/rest-up-biopharma-trumps-drug-pricing-policy-is-coming-on-monday[/url] NIH terminated $1.8B in grants in 40 days under Trump administration: study By Nick Paul Taylor May 9, 2025 3:04am fiercebiotech.com Trump's new executive order targets gain-of-function research, citing unsupported 'lab leak' theory By Darren Incorvaia May 6, 2025 fiercebiotech.com